As of 2025-05-18, the Intrinsic Value of Hainan Shuangcheng Pharmaceuticals Co Ltd (002693.SZ) is (3.27) CNY. This 002693.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 7.06 CNY, the upside of Hainan Shuangcheng Pharmaceuticals Co Ltd is -146.30%.
The range of the Intrinsic Value is (7.09) - (2.27) CNY
Based on its market price of 7.06 CNY and our intrinsic valuation, Hainan Shuangcheng Pharmaceuticals Co Ltd (002693.SZ) is overvalued by 146.30%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | (7.09) - (2.27) | (3.27) | -146.3% |
DCF (Growth 10y) | (2.25) - (6.35) | (3.11) | -144.1% |
DCF (EBITDA 5y) | (2.62) - (3.54) | (1,234.50) | -123450.0% |
DCF (EBITDA 10y) | (2.42) - (3.43) | (1,234.50) | -123450.0% |
Fair Value | -0.96 - -0.96 | -0.96 | -113.59% |
P/E | (9.43) - (8.57) | (8.50) | -220.4% |
EV/EBITDA | (5.67) - (3.36) | (4.83) | -168.5% |
EPV | (0.72) - (0.89) | (0.80) | -111.4% |
DDM - Stable | (1.61) - (7.87) | (4.74) | -167.2% |
DDM - Multi | (1.62) - (6.47) | (2.63) | -137.2% |
Market Cap (mil) | 2,927.71 |
Beta | 2.61 |
Outstanding shares (mil) | 414.69 |
Enterprise Value (mil) | 3,095.36 |
Market risk premium | 6.13% |
Cost of Equity | 9.27% |
Cost of Debt | 5.00% |
WACC | 8.97% |